Adam C Reese

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. doi request reprint Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis
    Adam C Reese
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland Electronic address
    J Urol 190:2033-8. 2013
  2. doi request reprint Natural history of untreated renal cell carcinoma with venous tumor thrombus
    Adam C Reese
    Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA Electronic address
    Urol Oncol 31:1305-9. 2013
  3. doi request reprint Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system
    Adam C Reese
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21224, USA
    Urology 80:1075-9. 2012
  4. doi request reprint The quantitative Gleason score improves prostate cancer risk assessment
    Adam C Reese
    Department of Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    Cancer 118:6046-54. 2012
  5. doi request reprint Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, California 94143, USA
    J Urol 185:1615-20. 2011
  6. doi request reprint Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus
    Jared M Whitson
    Department of Urology, University of California, San Francisco, CA 94143, USA
    Urol Oncol 31:259-63. 2013
  7. doi request reprint Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94115, USA
    J Urol 186:2228-32. 2011
  8. doi request reprint Inaccuracies in assignment of clinical stage for localized prostate cancer
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA
    Cancer 117:283-9. 2011
  9. pmc Laparoscopic and robotic radical prostatectomy outcomes in obese and extremely obese men
    Debasish Sundi
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Urology 82:600-5. 2013
  10. pmc Outcomes of active surveillance for men with intermediate-risk prostate cancer
    Matthew R Cooperberg
    University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    J Clin Oncol 29:228-34. 2011

Detail Information

Publications14

  1. doi request reprint Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis
    Adam C Reese
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland Electronic address
    J Urol 190:2033-8. 2013
    ..15 ng/ml, biopsy Gleason score 6 or less, 2 or fewer positive biopsy cores and 50% or less involvement of any biopsy core. We hypothesized that these criteria may be excessively strict, precluding many men from active surveillance...
  2. doi request reprint Natural history of untreated renal cell carcinoma with venous tumor thrombus
    Adam C Reese
    Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA Electronic address
    Urol Oncol 31:1305-9. 2013
    ..We aimed to describe the natural history of this disease, and to identify prognostic factors associated with disease-specific survival...
  3. doi request reprint Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system
    Adam C Reese
    James Buchanan Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21224, USA
    Urology 80:1075-9. 2012
    ..To analyze the National Comprehensive Cancer Network prostate cancer guidelines pretreatment risk groups in a contemporary series of patients treated with radical prostatectomy...
  4. doi request reprint The quantitative Gleason score improves prostate cancer risk assessment
    Adam C Reese
    Department of Urology, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    Cancer 118:6046-54. 2012
    ..They hypothesize that the qGS can improve prostate cancer risk stratification and help prevent the overtreatment of patients with clinically indolent tumors...
  5. doi request reprint Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, California 94143, USA
    J Urol 185:1615-20. 2011
    ..In a population based cohort we determined whether an increase in the number of lymph nodes removed is associated with improved disease specific survival of patients with renal cell carcinoma treated with nephrectomy...
  6. doi request reprint Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus
    Jared M Whitson
    Department of Urology, University of California, San Francisco, CA 94143, USA
    Urol Oncol 31:259-63. 2013
    ..To identify prognostic factors for renal cell carcinoma (RCC) with venous tumor thrombus (VTT) and determine the significance of thrombus level on survival...
  7. doi request reprint Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California 94115, USA
    J Urol 186:2228-32. 2011
    ..2 ng/ml) accurately reflects measures performed in the traditional range (prostate specific antigen greater than 0.2 ng/ml)...
  8. doi request reprint Inaccuracies in assignment of clinical stage for localized prostate cancer
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA
    Cancer 117:283-9. 2011
    ..One explanation for this lack of predictive power may be the inaccurate application of staging criteria...
  9. pmc Laparoscopic and robotic radical prostatectomy outcomes in obese and extremely obese men
    Debasish Sundi
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Urology 82:600-5. 2013
    ..To evaluate the operative and pathologic outcomes of laparoscopic radical prostatectomy and robot-assisted radical prostatectomy in men with progressive changes in body mass index (BMI) category...
  10. pmc Outcomes of active surveillance for men with intermediate-risk prostate cancer
    Matthew R Cooperberg
    University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
    J Clin Oncol 29:228-34. 2011
    ..Current risk stratification schema identify patients with low-risk disease who are presumed to be most suitable for AS. However, some men with higher risk disease also elect AS; outcomes for such men have not been widely reported...
  11. doi request reprint Factors associated with surgery in patients with renal cell carcinoma and venous tumor thrombus
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, CA, USA
    BJU Int 107:729-34. 2011
    ..Little is known about the factors influencing the decision to pursue surgery versus conservative management in patients with RCC and venous tumour thrombus...
  12. doi request reprint High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer
    Christian P Pavlovich
    James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Md Electronic address
    Urol Oncol 32:34.e27-32. 2014
    ..To determine how high-resolution transrectal ultrasound (HiTRUS) compares with conventional TRUS (LoTRUS) for the visualization of prostate cancer...
  13. doi request reprint Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease
    Adam C Reese
    Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA
    J Urol 184:114-9. 2010
    ..We hypothesize that in the context of data available from a contemporary biopsy, clinical stage no longer offers meaningful independent prognostic information for clinically localized prostate cancer...
  14. doi request reprint Emphysematous cystitis
    Adam C Reese
    Department of Urology, School of Medicine, University of California, San Francisco, California 94143, USA
    Urology 75:1315-6. 2010
    ..A conservative treatment approach using antibiotics and bladder catheterization is typically successful, with a complication rate of only 18.8%...